DeepHealth is a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), revolutionizing radiology through advanced artificial intelligence. The company empowers breakthroughs in care through imaging by developing comprehensive solutions that address the entire radiology continuum - from disease detection and assessment to monitoring and treatment planning. DeepHealth's technology supercharges radiology workflows with cloud-native, AI-infused informatics that dramatically improve clinical accuracy and operational efficiency.
At the heart of DeepHealth's portfolio is DeepHealth OS, a pioneering cloud-native operating system that unifies data across clinical and operational workflows while personalizing AI-powered workspaces for everyone in the radiology ecosystem. The company's solutions span two main categories: Enterprise Imaging (including Diagnostic Suite, Operations Suite, and TechLive) and Population Health (featuring specialized suites for breast, prostate, chest/thyroid, and neuro imaging). With deployments across 300+ sites globally and support for more than 10 million mammograms annually, DeepHealth's FDA-cleared AI applications have demonstrated measurable impact - including a 21% increase in breast cancer detection rates in landmark studies published in Nature Health.
